Core Biotherapeutics

Unlocking the power of transcription factors to reverse diseases

Core Bio’s REPROGRAM AI platform was built to overcome the limitations of conventional transcription-factor (TF) drug discovery by identifying the TFs that control diseased networks – in their biological context, not in isolation – and designing drugs that precisely block those TFs to reprogram the network and reverse disease.

REPROGRAM AI overview

Network library from >10M cells & 11k patients

Selects dominant targets from networks

Designs potent & selective TF motifs drugs

Reprograms
networks to reverse diseases

Multi-TF decoy therapeutics

COR-hyperOligo decoys block multiple TFs with a single compound.  COR-H compounds mimic the DNA motif of their target TFs and bind them before they bind the genome to regulate pathological genes.

Oral DNA binding small molecules

COR-Small molecules combine DNA motif potency, specificity and oral properties. COR-S compounds bind to specific TF motifs on the genome, preventing TF access to those specific sites to regulate pathological genes.

Scroll to Top